Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
US Stock MarketDetailed Quotes
RCKT Rocket Pharmaceuticals
- 7.405
- +0.265+3.71%
Trading Apr 24 12:26 ET
789.59MMarket Cap-2.71P/E (TTM)
7.500High7.105Low735.25KVolume7.150Open7.140Pre Close5.40MTurnover0.91%Turnover RatioLossP/E (Static)106.63MShares26.98052wk High1.70P/B598.20MFloat Cap4.55052wk Low--Dividend TTM80.78MShs Float67.480Historical High--Div YieldTTM5.53%Amplitude4.550Historical Low7.348Avg Price1Lot Size
About Rocket Pharmaceuticals Company
Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms. Its clinical program is an LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer. The company was founded on July 7, 1999 and is headquartered in Cranbury, NJ.
Company Profile
SymbolRCKT
Company NameRocket Pharmaceuticals
Listing DateFeb 18, 2015
Issue Price6.00
Founded1999
CEODr. Gaurav Shah, M.D.
MarketNASDAQ
Employees299
Fiscal Year Ends12-31
Address9 Cedarbrook Drive
CityCranbury
ProvinceNew Jersey
CountryUnited States of America
Zip Code08512
Phone1-609-659-8001
Websitehttp://www.rocketpharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Gaurav Shah, M.D.
- Director and Chief Executive Officer
- 8.01M
- Martin Wilson, J.D.
- Chief Corporate Officer, Senior Vice President, General Counsel and Chief Compliance Officer
- --
- Jonathan Schwartz, M.D.
- Chief Medical Officer and Chief Gene Therapy Officer
- 3.16M
- Dr. Kinnari Patel, M.B.A.,Pharm.D.
- President, Chief Operating Officer and Head of R&D
- 4.85M
- Raj Prabhakar
- Chief Business Officer and Senior Vice President
- --
- Mayo Pujols
- Chief Technical Officer and Executive Vice President
- 4.38M
- Aaron Ondrey
- Chief Financial Officer
- --
- Sarbani Chaudhuri
- Chief Commercial and Medical Affairs Officer
- --
- John Militello, C.P.A.
- Vice President, Finance, Senior Controller, Treasurer and Principal Accounting Officer
- 1.53M
- Dr. Roderick Wong, M.D.
- Chairman of the Board
- 409.99K
- Piratip Pratuwan
- Director
- --
- Dr. Mikael Dolsten, M.D.
- Director
- --
- Robert Keith Woods
- Independent Director
- 568.70K
- Pedro P. Granadillo
- Independent Director
- 429.98K
- David P. Southwell
- Independent Director
- 399.99K
- Carsten Boess
- Independent Director
- 427.49K
- Dr. Gotham Makker, M.D.
- Independent Director
- 399.99K
- Dr. Fady Ibraham Malik, M.D.,PhD
- Independent Director
- 399.99K
- Dr. Elisabeth Bjork, M.D.,PhD
- Independent Director
- 409.99K
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
